[Federal Register Volume 85, Number 74 (Thursday, April 16, 2020)]
[Notices]
[Pages 21256-21257]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08017]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Interagency Coordinating Committee on the Validation of 
Alternative Methods; Notice of Public Webcast; Request for Public Input

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Interagency Coordinating Committee on the Validation of 
Alternative Methods (ICCVAM) will hold a public forum to share 
information and facilitate direct communication of ideas and 
suggestions from stakeholders. Interested persons may view the 
presentations by webcast. Time will be set aside for questions and 
public statements on the topics discussed. Registration is required for 
both webcast viewing and oral statements. Information about the meeting 
and registration are available at https://ntp.niehs.nih.gov/go/iccvamforum-2020.

DATES: 
    Webcast: May 21, 2020, 9:00 a.m. to approximately 3:00 p.m. EDT.
    Registration for Webcast: April 17, 2020, until 3:00 p.m. EDT May 
21, 2020.
    Registration for Oral Statements: April 17, 2020, until 4:00 p.m. 
EDT May 8, 2020.
    Registration to view the webcast and present oral public statements 
is required.

ADDRESSES: 
    Meeting web page: A preliminary agenda will be posted by May 1 at 
https://ntp.niehs.nih.gov/go/iccvamforum-2020.
    Webcast: The meeting will be webcast; information to connect to the 
webcast will be provided to those who register for viewing.

FOR FURTHER INFORMATION CONTACT: Dr. Nicole Kleinstreuer, Acting 
Director, National Toxicology Program Interagency Center for the 
Evaluation of Alternative Toxicological Methods (NICEATM), Division of 
NTP, NIEHS, P.O. Box 12233, K2-17, Research Triangle Park, NC 27709. 
Phone: 984-287-3150, Email: [email protected]. Hand Deliver/
Courier address: 530 Davis Drive, Room K2021, Morrisville, NC 27560.

SUPPLEMENTARY INFORMATION: 
    Background: ICCVAM, a congressionally mandated committee, promotes 
the development and validation of alternative testing strategies that 
protect human health and the environment while replacing, reducing, or 
refining animal use.
    ICCVAM's goals include promotion of national and international 
partnerships between governmental and nongovernmental groups, including 
academia, industry, advocacy groups, and other key stakeholders. To 
foster

[[Page 21257]]

these partnerships ICCVAM initiated annual public forums in 2014 to 
share information and facilitate direct communication of ideas and 
suggestions from stakeholders (79 FR 25136).
    This year's meeting will be held on May 21, 2020. Due to 
restrictions on in-person gatherings amid ongoing public health 
concerns, the public forum will be presented via webcast only. NICEATM 
and ICCVAM members will give presentations on current activities 
related to the development and validation of alternative test methods 
and approaches, including activities relevant to implementation of the 
strategic roadmap for establishing new approaches to evaluate the 
safety of chemicals and medical products in the United States (83 FR 
7487).
    There will be opportunities for registered participants to ask 
clarifying or follow-up questions of the ICCVAM members about their 
presentations. Instructions for submitting these questions will be 
provided via email prior to the webcast. The agenda will also include 
time for public oral statements relevant to the ICCVAM mission and 
current activities from participants who have registered to do so in 
advance.
    Preliminary Agenda and Other Meeting Information: A preliminary 
agenda will be posted by May 1 at https://ntp.niehs.nih.gov/go/iccvamforum-2020. Interested individuals are encouraged to visit this 
web page to stay abreast of the most current meeting information.
    Webcast and Registration: This webcast is open to the public. 
Registration for the webcast is required and is open through 3:00 p.m. 
EDT on May 21, 2020 at https://ntp.niehs.nih.gov/go/commprac-2020. 
Registrants will receive instructions on how to access and participate 
in the webcast in the email confirming their registration.
    Individuals with disabilities who need accommodation to participate 
in this event should contact Elizabeth Maull at phone: (984) 287-3157 
or email: [email protected]. TTY users should contact the Federal TTY 
Relay Service at (800) 877-8339. Requests should be made at least five 
business days in advance of the event.
    Request for Oral Public Statements: In addition to time for 
clarifying or follow-up questions following scheduled presentations, 
time will be allotted during the meeting for oral public statements 
with associated slides on topics relevant to ICCVAM's mission. Separate 
registration for those wishing to provide public statements is required 
and is open through May 8, 2020 at https://ntp.niehs.nih.gov/go/commprac-2020. Any participant registered for the webcast may ask 
clarifying questions during the appropriate times in the agenda. The 
additional registration is only required for those who wish to give 
separate public statements. The number and length of presentations may 
be limited based on available time. Submitters will be identified by 
their name and affiliation and/or sponsoring organization, if 
applicable. Persons submitting public statements and/or associated 
slides should include their name, affiliation (if any), mailing 
address, telephone, email, and sponsoring organization (if any) with 
the document. National Toxicology Program guidelines for public 
statements are at http://ntp.niehs.nih.gov/ntp/about_ntp/guidelines_public_comments_508.pdf.
    Participants registered to present oral public statements must 
email their statement to [email protected] by May 8, 2020, 
to allow time for review by NICEATM and ICCVAM and posting to the 
meeting page prior to the forum. Persons presenting oral public 
statements will be contacted to arrange the logistics of their 
presentations. Written statements may supplement and expand the oral 
presentation. Public statements will be distributed to NICEATM and 
ICCVAM members before the meeting.
    Responses to this notice are voluntary. No proprietary, classified, 
confidential, or sensitive information should be included in statements 
submitted in response to this notice or presented during the meeting. 
This request for input is for planning purposes only and is not a 
solicitation for applications or an obligation on the part of the U.S. 
Government to provide support for any ideas identified in response to 
the request. Please note that the U.S. Government will not pay for the 
preparation of any information submitted or for its use of that 
information.
    Background Information on ICCVAM and NICEATM: ICCVAM is an 
interagency committee composed of representatives from 16 federal 
regulatory and research agencies that require, use, generate, or 
disseminate toxicological and safety testing information. ICCVAM 
conducts technical evaluations of new, revised, and alternative safety 
testing methods and integrated testing strategies with regulatory 
applicability and promotes the scientific validation and regulatory 
acceptance of testing methods that more accurately assess the safety 
and hazards of chemicals and products and replace, reduce, or refine 
(enhance animal well-being and lessen or avoid pain and distress) 
animal use.
    The ICCVAM Authorization Act of 2000 (42 U.S.C. 285l-3) establishes 
ICCVAM as a permanent interagency committee of NIEHS and provides the 
authority for ICCVAM involvement in activities relevant to the 
development of alternative test methods. Additional information about 
ICCVAM can be found at https://ntp.niehs.nih.gov/go/iccvam.
    NICEATM administers ICCVAM, provides scientific and operational 
support for ICCVAM-related activities, and conducts and publishes 
analyses and evaluations of data from new, revised, and alternative 
testing approaches. NICEATM and ICCVAM work collaboratively to evaluate 
new and improved testing approaches applicable to the needs of U.S. 
federal agencies. NICEATM and ICCVAM welcome the public nomination of 
new, revised, and alternative test methods and strategies for 
validation studies and technical evaluations. Additional information 
about NICEATM can be found at https://ntp.niehs.nih.gov/go/niceatm.

    Dated: April 7, 2020.
Brian R. Berridge,
Associate Director, National Toxicology Program.
[FR Doc. 2020-08017 Filed 4-15-20; 8:45 am]
 BILLING CODE 4140-01-P